At #AACR26, Archana Balan (@archana__balan @hopkinskimmel) discuss how multi-modal, multi-omic analyses are uncovering why NSCLC tumors develop resistance to immunotherapy.

Findings point to dynamic genomic and transcriptomic changes, including EMT, lineage plasticity, stem-like states and immune reprogramming, revealing new paths for treatment.

#MoffittAACR26